TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference

TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference GlobeNewswire May 22, 2025 MALVERN, Pa., May 22, 2025 (GLOBE NEWSWIRE) — TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in the 2025 Jefferies Global Healthcare Conference. TELA's […]

Kelly Announces Participation in June 2025 Investor Conferences

Kelly Announces Participation in June 2025 Investor Conferences GlobeNewswire May 22, 2025 TROY, Mich., May 22, 2025 (GLOBE NEWSWIRE) — Kelly (Nasdaq: KELYA, KELYB), a leading global specialty talent solutions provider, today announced the Company will participate in two investor conferences in June. Kelly will present at the Baird 2025 Global Consumer, Technology & Services

LPL Financial Reports Monthly Activity for April 2025

LPL Financial Reports Monthly Activity for April 2025 GlobeNewswire May 22, 2025 SAN DIEGO, May 22, 2025 (GLOBE NEWSWIRE) — LPL Financial LLC (“LPL Financial”), a wholly owned subsidiary of LPL Financial Holdings Inc. (Nasdaq: LPLA) (the “Company”), today released its monthly activity report for April 2025. Total advisory and brokerage assets at the end

“Finish Line Campaign” Erases More than $83,000 of debt for Howard Community College Graduates, Continuing Students

COLUMBIA, MD, May 22, 2025 (GLOBE NEWSWIRE) — Howard Community College (HCC) President Daria J. Willis today announced more than $83,000 of cleared institutional balances for graduating and continuing students at the institution. The 'Finish Line' fundraising initiative launched by the Howard Community College Educational Foundation (HCCEF) invited donors and supporters to help eliminate outstanding

“Finish Line Campaign” Erases More than $83,000 of debt for Howard Community College Graduates, Continuing Students

“Finish Line Campaign” Erases More than $83,000 of debt for Howard Community College Graduates, Continuing Students GlobeNewswire May 22, 2025 COLUMBIA, MD, May 22, 2025 (GLOBE NEWSWIRE) — Howard Community College (HCC) President Daria J. Willis today announced more than $83,000 of cleared institutional balances for graduating and continuing students at the institution. The 'Finish

NASA Astronaut to Answer Questions from Students in Washington State

NASA astronaut and Spokane, Washington, native Anne McClain will participate in an event with students from the Mobius Discovery Center located in her hometown. McClain will answer prerecorded questions submitted by students from aboard the International Space Station. https://mma.prnewswire.com/media/2694637/NASA_astronaut_Anne_McClain.jpg Watch the 20-minute Earth-to-space call on the NASA STEM YouTube Channel. The event will take place

Gyre Therapeutics Announces Proposed Underwritten Public Offering of Common Stock

(NASDAQ:GYRE), SAN DIEGO, May 22, 2025 (GLOBE NEWSWIRE) — Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company focused on organ fibrosis, today announced that it has commenced an underwritten public offering of shares of its common stock. In addition, Gyre is expected to grant the underwriters of the offering an option for a

Freehold Royalties Announces TSX Approval for Normal Course Issuer Bid

(TSX:FRU), CALGARY, Alberta, May 22, 2025 (GLOBE NEWSWIRE) — Freehold Royalties Ltd. (“Freehold” or the “Company“) (TSX – FRU) is pleased to announce that the Toronto Stock Exchange (the “TSX“) has accepted Freehold's notice of intention to commence a normal course issuer bid (the “NCIB“). Under the NCIB, Freehold may purchase up to 13,699,733 common

Copley Acquisition Corp Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about June 2, 2025

(NYSE:COPLU),(NYSE:COPL),(NYSE:COPLW), HONG KONG, May 22, 2025 (GLOBE NEWSWIRE) — Copley Acquisition Corp (NYSE: COPLU) (the “Company“) announced that holders of the units sold in the Company's initial public offering of 17,250,000 units, which includes 2,250,000 units issued pursuant to the exercise by the underwriters of their overallotment option, completed on May 2, 2025 (the “Offering“)

Immix Biopharma Announces Positive Results for NXC-201 at ASCO Oral Presentation, Enabling Pathway to Best-in-Class Therapy for relapsed/refractory AL Amyloidosis

Immix Biopharma Announces Positive Results for NXC-201 at ASCO Oral Presentation, Enabling Pathway to Best-in-Class Therapy for relapsed/refractory AL Amyloidosis GlobeNewswire May 22, 2025 Immix Biopharma today reported ASCO abstract results from its U.S. multi-center NEXICART-2 Phase 1/2 clinical trial of NXC-201 demonstrating strong efficacy and favorable safety. – NXC-201 demonstrated a complete response (CR)

Scroll to Top